RU 10. IL-6 2174G > C polymorphism and cancer risk: A meta - analysis involving 29,377 cases and 37,739 controls
Research Urology

RU 10. IL-6 2174G > C polymorphism and cancer risk: A meta - analysis involving 29,377 cases and 37,739 controls

Bin Xu1, Xiao-Bing Niu2, Zi-Dun Wang2, Wei Cheng2, Na Tong1, Yuan-Yuan Mi2, Zhi-Chao Min2, Jun Tao2, Peng-Chao Li2, Wei Zhang2, Hong-Fei Wu2, Zheng- Dong Zhang1, Zeng-Jun Wang2, Li-Xin Hua2, Ning-Han Feng2, Xin-Ru Wang3

1Department of Molecular and Genetic Toxicology, Cancer Center of Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China; 2Department of Urology, Laboratory of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China; 3Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing 210029, China

Interleukin-6 (IL-6) is a multifunctional cyto- kine involved in different physiologic and pathophysiologic processes and plays important roles in the etiology of cancer. The -174G[C polymorphism of the IL-6 gene influences IL-6 transcription and has been implicated in cancer risk . However, published data have been conflicting. To derive a more precise estimation of the relationship, a meta-analysis of 29,377 cancer cases and 37,739 controls from 50 published case-control studies was performed. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association between -174G[C polymorphism and cancer risk. Overall meta-analysis indicated that no association was found between -174G[C genotypes and cancer risk. However, the positive association was found in bladder cancer (OR=4.33, 95% CI:1.93-9.71 for CC vs. GC, OR=2.81, 95% CI:1.39-5.68 for CC vs. GG, and OR=2.19, 95% CI:1.32-3.64 for CC vs. GG/GC), and among Asians (OR=2.08, 95% CI:1.07-4.06 for CC vs. GG, and OR=2.20, 95% CI:1.02-4.74 for CC vs. GG/GC) and Af r icans (OR=1.61, 95% CI:1.07-2.42 for GC vs. GG). This metaanalysis showed the evidence that the -174G[C of the IL-6 gene was a low-penetrance suscepti-bility gene for bladder cancer. Further larger, preferably prospective studies are needed to confirm this relationship.

Key words

IL-6; Polymorphism; Cancer risk; Meta-analysis; Molecular epidemiology

DOI: 10.3978/j.issn.2223-4683.2012.s191

Article Options

Download Citation